New supramolecular alzheimer’s drugs

New supramolecular alzheimers drugs | Chemistry World – Supramolecular chemistry could provide a new avenue in the treatment of Alzheimer’s disease, say scientists in China. The group demonstrates for the first time that supramolecular complexes can inhibit the aggregation of a peptide thought to cause Alzheimer’s disease. Reference: H Yu et al, Chem. Sci., 2012, DOI: 10.1039/c2sc20372c

New supramolecular alzheimers drugs | Chemistry World – Supramolecular chemistry could provide a new avenue in the treatment of Alzheimer’s disease, say scientists in China. The group demonstrates for the first time that supramolecular complexes can inhibit the aggregation of a peptide thought to cause Alzheimer’s disease.

[cite]10.1039/c2sc20372c[/cite]

Author: Robert Slinn

Robert Slinn contributes to ChemSpy’s “Slinn Pickings”